Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy

Journal of Viral Hepatitis

Volumn 15, Issue 6, 2008, Pages 427-433

  De Ledinghen V ^a,b   Barreiro, P ^c   Foucher, J ^a   Labarga, P ^c   Castera L ^a   Vispo, M E ^c   Bernard, P H ^d   Martin Carbonero, L ^c   Neau, D ^e   Garcia Gasco P ^c   Merrouche, W ^a   Soriano, V ^c  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b INSERM   (France)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d HÔPITAL SAINT ANDRÉ   (France)

^e HÔPITAL PELLEGRIN   (France)

Author keywords

Coinfection; FibroScan; Hepatitis C; HIV; Liver fibrosis; Transient elastography

Indexed keywords

AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; VIRUS RNA;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CD4 LYMPHOCYTE COUNT; CHRONIC HEPATITIS; DISEASE SEVERITY; ELASTOGRAPHY; FEMALE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY MASS INDEX; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS;

EID: 43549127153     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2007.00962.x     Document Type: Article

References (32)

1. Martin-Carbonero L, Benhamou Y, Puoti M et al. Incidence and predictors of severe liver fibrosis in HIV-infected patients with chronic hepatitis C: a European collaborative study. Clin Infect Dis 2004 38 : 128 133.
2. Mohsen A, Easterbrook P, Taylor C et al. Impact of HIV infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut 2003 52 : 1035 1040.
3. Rosenthal E, Poiree M, Pradier C et al. Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study). AIDS 2003 17 : 1803 1809.
4. Kramer J, Giordano T, Souchek J, El-Serag H. Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era. J Hepatol 2005 42 : 309 314.
5. Kramer J, Giordano T, Souchek J, Richardson P, Hwang L, El-Serag H. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C. Am J Gastroenterol 2005 100 : 56 63.
6. Brau N, Salvatore M, Rios-Bedoya C et al. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol 2006 44 : 47 55.
7. Benhamou Y, Bochet M, Di Martino V et al. Liver fibrosis progression in HIV and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999 30 : 1054 1058.
8. Cadranel J, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000 32 : 477 481.
9. Huang J, Hsiah M, Dai C et al. The incidence and risks of liver biopsy in non-cirrhotic patients: an evaluation of 3806 biopsies. Gut 2007 56 : 737 738.
10. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003 38 : 1449 1457.
11. Regev A, Berho M, Jeffers L et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002 97 : 2614 2618.
12. Castera L, Vergniol J, Foucher J et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005 128 : 343 350.
13. de Ledinghen V, Douvin C, Kettaneh A et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 2006 41 : 175 179.
14. Ziol M, Handra-Luca A, Kettaneh A et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005 41 : 48 54.
15. Sandrin L, Fourquet B, Hasquenoph JM et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003 29 : 1705 1713.
16. Wai C, Greenson J, Fontana R et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003 38 : 518 526.
17. Sterling RK, Lissen E, Clumeck N et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006 43 : 1317 1325.
18. Forns X, Ampurdanes S, Llovet JM et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002 36 : 986 992.
19. Soto B, Sanchez-Quijano A, Rodrigo L et al. HIV infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997 26 : 1 5.
20. Monto A, Kakar S, Dove L, Bostrom A, Miller E, Wright T. Contributions to hepatic fibrosis in HIV-HCV coinfected and HCV monoinfected patients. Am J Gastroenterol 2006 101 : 1509 1515.
21. Di Martino V, Rufat P, Boyer N et al. The influence of HIV coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology 2001 34 : 1193 1199.
22. Puoti M, Bonacini M, Spinetti A et al. Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and HIV. J Infect Dis 2001 183 : 134 137.
23. Sulkowski M, Mehta S, Torbenson M et al. Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus. AIDS 2005 19 : 585 592.
24. Maida I, Nunez M, Rios MJ et al. Severe liver disease associated with prolonged exposure to antiretroviral drugs. J Acquir Immune Defic Syndr 2006 42 : 177 182.
25. Macias J, Castellano V, Merchante N et al. Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine. AIDS 2004 18 : 767 774.
26. Julg B, Bogner J, Goebel F. Severe hepatotoxicity associated with the combination of enfuvirtide and tipranavir/ritonavir: case report. AIDS 2006 20 : 1563.
27. Soriano V, Maida I, Nunez M et al. Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies. Antivir Ther 2004 9 : 987 992.
28. Soriano V, Labarga P, Ruiz-Sancho A, Garcia-Samaniego J, Barreiro P. Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin. AIDS 2006 20 : 2225 2227.
29. Barreiro P, Labarga P, Martin-Carbonero L et al. Sustained virological response following HCV therapy is associated with non-progression of liver fibrosis in HCV/HIV-coinfected patients. Antivir Ther 2006 11 : 869 877.
30. Foucher J, Chanteloup E, Vergniol J et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006 55 : 403 408.
31. Ganne-Carrie N, Ziol M, de Ledinghen V et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006 44 : 1511 1517.
32. Soriano V, Martin-Carbonero L, Garcia-Samaniego J. Treatment of chronic hepatitis C virus infection: we must target the virus or liver fibrosis? AIDS 2003 17 : 751 753.